Conferences - Results from #8900

Viewing 8901-8920 of 11721 articles

CUA 2017: Adjuvant vs. Salvage Radiotherapy for Patients with Adverse Pathological Findings After Radical Prostatectomy: A Decision Analysis

CUA 2017: Incidence and Predictors of Clinical Depression in Men with Prostate Cancer

CUA 2017: Statin Use and Time to Prostate Cancer Progression in Men Undergoing Active Surveillance

CUA 2017: Early Cardiovascular Morbidity in a Pilot Prospective Randomized Trial Comparing Luteinizing Hormone-Releasing Hormone Agonist and Antagonist Among Patients with Advanced Prostate Cancer

CUA 2017: Outcomes of Urothelial Bladder Cancer Patients who had Previous Upper Tract Urothelial Disease

CUA 2017: Predictors of Early Disease-Specific Mortality Among Patients with Prostate Adenocarcinoma and Bone Metastasis at Diagnosis

CUA 2017: Outcomes of an Aggressive Biopsy Strategy in Young Men with Prostate-Specific Antigen Between 0.5 and 2.5

CUA 2017: Magnetic Resonance Imaging-Targeted vs. Systematic Biopsies in Men on Active Surveillance: Results of a Prospective, Randomized Canadian Urology Research Consortium Trial

CUA 2017: Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer

CUA 2017: Association Between Germline Genetic Variation and Progression in Men with Low-Risk Prostate Cancer on Active Surveillance

CUA 2017: Prostate-Specific Antigen Levels in Men Aged 60-70 and Development of Lethal Prostate Cancer Over 30 Years: Implications for Risk-Stratified Screening

CUA 2017: Defining a Cohort of Men Who May Not Require Repeat Prostate Biopsy Based on Negative Predictive Value of PCA3 and MRI Combined: The Double-Negative Effect

CUA 2017: Chemotherapy and Novel Hormones in “Low Volume” Hormone-Sensitive Metastatic Prostate Cancer

CUA 2017: Immuno-Oncology Update in Advanced Bladder Cancer

CUA 2017: State of the Art Immunotherapy for Urologic Cancers.

CUA 2017: Update on Bladder Preservation in Muscle Invasive Disease

CUA 2017: PSMA-Targeted Radionuclide Therapies in Treatment of Prostate Cancer

CUA 2017: The Role of Testosterone Nadir Levels in Androgen Deprivation Therapy

CUA 2017: Optimizing Active Surveillance for Prostate Cancer

CUA 2017: Role of MRI in Diagnosing Prostate Cancer

441
442
443
444
445
446
447
448
449
450